EMA Raises Industry Fees: Now Almost €287,000 For A New Drug Approval
Executive Summary
The European Medicines Agency has increased the fees it charges to industry by 1.7%, in line with the EU inflation rate. It has also produced a number of charts showing the typical fees payable for new drug applications that include several strengths and presentations, and for site inspections involving different kinds of manufacturing activities